Streetbeat News

Analyst Ratings

SHO

JP Morgan analyst Sean Meakim maintains an Underweight rating on Sunstone Hotel Invts (NYSE:SHO) and raises the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:38 pm

RWAY

JP Morgan analyst Melissa Wedel maintains an Overweight rating on Runway Gwth Fin (NASDAQ:RWAY) and raises the price target from $13 to $13.5.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:33 pm

BMBL

RBC Capital analyst Brad Erickson has maintained an 'Outperform' rating on Bumble (NASDAQ:BMBL), but lowered the price target from $23 to $16.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:33 pm

HLNE

JP Morgan analyst Kenneth Worthington maintains an Overweight rating on Hamilton Lane (NASDAQ:HLNE) and raises the price target from $102 to $103.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:31 pm

DHI

A significant investor has adopted a bearish approach towards D.R. Horton (NYSE:DHI), with unusual options activity being observed. The investor's identity remains unknown, but such a move usually suggests insider knowledge. The trading activity indicates that significant investors are aiming for a price territory stretching from $90.0 to $135.0 for D.R. Horton over the recent three months. Analysts from Barclays, Goldman Sachs, and Raymond James have maintained positive ratings on D.R. Horton, with price targets of $130, $131, and $140 respectively.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 7:31 pm

CG

JP Morgan analyst Kenneth Worthington maintains an Overweight rating on Carlyle Group (NASDAQ:CG) and raises the price target from $35 to $38.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:29 pm

BSY

RBC Capital analyst Matthew Hedberg maintains an Outperform rating on Bentley Systems (NASDAQ:BSY) and raises the price target from $59 to $61.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:28 pm

AKAM

RBC Capital analyst Rishi Jaluria maintains a 'Sector Perform' rating on Akamai Techs (NASDAQ:AKAM) and raises the price target from $97 to $115.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:26 pm

AHCO

RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on AdaptHealth (NASDAQ:AHCO), but lowered the price target from $18 to $13.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:24 pm

ADCT

RBC Capital analyst Gregory Renza has maintained an 'Outperform' rating on ADC Therapeutics (NYSE:ADCT), but lowered the price target from $7 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 7:22 pm